The economic, medical and societal benefits of in vitro diagnostic tests are often overlooked, despite the fact that these tests:
- improve patient care,
- contribute to protecting consumer health,
- help to limit healthcare spending, which is a major economic issue in every country throughout the world.
Improving patient care
Between 60% and 70% of medical decisions draw upon in vitro diagnostic test results.
Diagnostics have a significant impact on the quality of care provided:
- detecting and diagnosing disease more rapidly and at an earlier stage, even before symptoms occur,
- determining disease risk earlier,
- choosing more targeted, effective, and often less invasive treatments,
- monitoring treatment to effectively manage chronic diseases,
- estimating patient prognosis.
Protecting consumer health
Companies in the food-processing, pharmaceutical and cosmetics industries use specific diagnostic tests to check the microbiological quality of their products and the environment in which they are manufactured.
These quality control tools help to ensure the safety of products such as infant formula or vaccines, thus contributing to protect consumer health.
Positive impact on healthcare costs
Diagnostics play a major role in controlling healthcare spending, as an appropriate test carried out in good time can reduce the risk of trial-and-error treatment or over-prescription.
Only 1% of funds allocated to healthcare around the world is spent on diagnostic tests, yet they underpin a majority of medical decisions.
The cost of in vitro tests is generally very low compared with:
- the medical service provided,
- the savings generated by shortening the time taken to provide treatment and the duration of hospital stays.
Personalized medicine, the automation of the diagnostic process, and new software applications (consolidation and management of clinical data, treatment decision support, etc.) all serve to reinforce the role of in vitro diagnostics in improving the efficiency of healthcare systems.